FLT3 kinase inhibitor (KinSea)

N/A

Report date: 2025/03/20 14:58:42

Base Information

Drug NameFLT3 kinase inhibitor (KinSea)
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsHematologic DiseasesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKinSea Lead Discovery AS
China Registration ClassN/A

Develop Information

Active CompaniesKinSea Lead Discovery AS
Inactive CompaniesN/A
Active IndicationsHematologic DiseasesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A